Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 26, 2017
Patent Application Number
15298539
Date Filed
October 20, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to 1,2,4-oxadiazole and 1,2,4-thiadiazole compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (PD1) signaling pathway. The invention also refers to derivatives of the therapeutic agents. The invention also encompasses the use of the said therapeutic agents and derivatives for treatment of disorders via immunopotentiation comprising inhibition of immunosuppressive signal induced due to PD-1, PD-L1, or PD-L2 and therapies using them.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
